This program's development has been guided by the input of an advisory board, whose members represent a cross-section of the professional community and include representatives from the industry, U.S. Food and Drug Administration and various research organizations.
Linda Bakke, Research Trials Office Director, Fred Hutchinson Cancer Research Center
Priya Bondre, Regulatory Affairs, Bio-Rad Laboratories (Redmond, WA)
Charles Breen, District Director, U.S. Food and Drug Administration
Lizabeth Cardwell, Director, U.S. Food and Drug Administration, Seattle District
Celeste Corcoran, Director, Investigations Branch, U.S. Food and Drug Administration, Seattle District
Nancy Dunn, Grant and Contract Coordinator (retired), Grant and Contract Services, University of Washington
Donna Edgerton, Director, Clinical Operations, Sonus Pharmaceuticals
Scott Emerson, Professor, Biostatistics, University of Washington
David Emery, Research Associate Professor, Medicine/Medical Genetics, University of Washington
Martha Feldman, R.A.C., President, Drug & Dev Co., Inc.
Thomas Fleming, Professor and Chairman, Biostatistics, University of Washington
Jacqueline Gardner, Professor, Pharmacy, University of Washington
Daina Graham, Vice President, Regulatory Affairs and Quality Assurance SonoSite, Inc.
Russell Gripp, Director, Compliance Branch, U.S. Food and Drug Administration, Seattle District
Thomas Hazlet, Associate Professor, Pharmacy, University of Washington
Michael Hoffman, Vice President, Regulatory Affairs and Quality Systems, Liposonix, Inc.
Cindy Jacobs, M.D., Executive Vice President and Chief Medical Officer, OncoGeneX
Erica Jonlin, Regulatory Manager/Clinical Research Administrator, Gene Therapy and Stem Cell Research
Richard Kronmal, Professor, Biostatistics, University of Washington
Ella Mae Kurashige, R.N., M.S.N., Manager, Patient Education/Outcomes and Patient and Family Resource Center, Harborview Medical Center
Anna Mastroianni, Associate Professor, University of Washington School of Law
Ruth McBride, Scientific Director, Axio Research Corp.
Richard Meeks, HIPAA Compliance Officer, University of Washington Medicine
Sharon O'Grady, Manager, Clinical Research, Medtronic Physio-Control
Michael Owen, Regulatory/Counterterrorism Microbiologist, U.S. Food and Drug Administration Pacific, Regional Laboratory Northwest
David Pettenski, Supervisor, Medical Device Group, U.S. Food and Drug Administration, Seattle District
William Pitlick, Vice President for Product Development, Ocularis
Jeffrey Probstfield, Professor, Medicine, Cardiology, Fred Hutchinson Cancer Research Center
Janet Rea, Vice President, Poniard Pharmaceuticals
Ruth Scott, Chair, The Arthritis Foundation, Pacific Northwest Chapter
Danny Shen, Professor and Chairman, Pharmacy; Professor, Pharmaceutics, University of Washington
Gigi Streidl, Clinical Trials Administrative Manager, Office of the Dean of Medicine, University of Washington
Dee Sweeney, R.A.C., Principal, Sweeney Regulatory Consulting; Past President, Organization of Regulatory and Clinical Associates (ORCA)
Terry Sweeney, Sr. Vice President, Corporate Quality and Regulatory Affairs, Philips Medical Systems
Daniel Syrdal, Attorney, Heller Erhman, L.L.P.
David Szatmary, Vice Provost, University of Washington Educational Outreach
James Young III, Manager, Bioprocessing Services, Bayer Health Care
   
     |
ADVISORY BOARD
|